Insights
Publications
Publications |
Digital Healthcare 2026 – Trends & Developments
by Andreas Wildi and Annemarie LaggerPDF: 2410 KB
Publications |
Swiss pharmaceutical reimbursement and pricing: Ordinance Law Changes (KVV/KLV) as of January 2024: Today's Decision by the Swiss Federal Council (Bundesrat)
by Andreas Wildi and Celine WeberPDF: 204 KB
Publications |
Triennial review of medicines’ SL prices: Lessons learned from appeals won against the FOPH
by Celine Weber and Andreas WildiPDF: 208 KB
Publications |
The Revised Law on Human Genetic Testing
by Andreas Wildi, Lucina Herzog and Simon MazidiPDF: 171 KB
Publications |
Access to unapproved/non-listed drugs: A veritable maze
by Carole-Anne Baud, Reto Baumann, Jean-Christophe Devaud, Valérie Junod and Andreas WildiPDF: 1796 KB
Publications |
Pharmaceutical Advertising 2022 - Switzerland
by Andreas Wildi and Celine WeberPDF: 581 KB
Publications |
Commentary on Art. 5, 6 und 7a HMG
by Michael Isler [co-author], Andreas Wildi [co-author] and Stephanie Eggimann [co-author]
Publications |
Entry into force of the revised Swiss Medical Devices Ordinance and its implications for the medtech industry
by Andreas Wildi and Monja SieberPDF: 172 KB
Publications |
The Life Sciences Law Review Chapter 24 - Switzerland
by Celine Weber and Andreas WildiPDF: 334 KB
Publications |
Pharmaceutical Advertising – Switzerland
by Andreas Wildi and Celine WeberPDF: 470 KB
Publications |
Liberté de choix de la thérapie vs principe du caractère économique dans le domaine de la liste des spécialités
by Andreas Wildi, Daniel Staffelbach and Stephanie EggimannPDF: 308 KB
Publications |
Therapiewahlfreiheit vs. Wirtschaftlichkeitsgebot im Bereich der Spezialitätenliste
by Andreas Wildi, Daniel Staffelbach and Stephanie EggimannPDF: 315 KB
Publications |
Update: Postponement of EU Medical Device Regulation implementation due to COVID-19
by Andreas Wildi and Monja SieberPDF: 521 KB
Publications |
The Life Sciences Law Review Chapter 28 - Switzerland
by Andreas Wildi and Celine WeberPDF: 273 KB
Publications |
Postponement of EU Medical Device Regulation implementation due to COVID-19
by Andreas Wildi and Monja SieberPDF: 550 KB
Publications |
Handbook on Foodstuffs and Utility Articles law
by Annemarie Lagger, Andreas Wildi, Sophie Regenfuss, Celine Weber, Christine Leuch, Florian Roth, Hugh Reeves, Monja Sieber and Pandora Kunz-NotterPublications |
The distinction between food and therapeutic products
by Andreas Wildi and Sophie Regenfuss
Publications |
Life Science Law Update
by Andreas Wildi, Celine Weber and Felix TuchschmidPDF: 123 KB
Publications |
Life Science Law Update
by Andreas Wildi, Celine Weber and Felix TuchschmidPDF: 126 KB
Publications |
Life Science Law Update
by Andreas Wildi, Celine Weber and Felix TuchschmidPDF: 109 KB
Publications |
Life Science Law Update
by Andreas Wildi, Celine Weber and Felix TuchschmidPDF: 107 KB
Publications |
Life Science Law Update
by Andreas Wildi, Celine Weber and Felix TuchschmidPDF: 125 KB
Publications |
The Life Sciences Law Review Chapter 29 - Switzerland
by Andreas Wildi and Celine WeberPDF: 262 KB
Publications |
Pharmaceutical Advertising - Switzerland
by Andreas Wildi and Celine WeberPDF: 382 KB
Publications |
Chapter 16: Switzerland
by Andreas Wildi [co-author], Markus R. Frick [co-author], Marija Petrovic [co-author], Benno Fischer-Siddiqui [co-author] and Monika Kawa [co-author]Publications |
Chapter 16: Switzerland
by Andreas Wildi [co-author], Markus R. Frick [co-author], Marija Petrovic [co-author], Benno Fischer-Siddiqui [co-author] and Monika Kawa [co-author]
Publications |
Limitation of medicines in health insurance law: where is the boundary with rationing exceeded?
by Bernhard Rütsche and Andreas WildiPDF: 261 KB
Publications |
Do high medicine prices restrict doctors" therapeutic freedom?
by Andreas WildiPDF: 168 KB
Publications |
Compendium of contracts in Pharma and Life Sciences, chapter with regard to legal specifics in Switzerland
by Andreas Wildi [co-author], Simon Holzer [co-author] and Michael Ritscher [co-author]
Publications |
Side effects of a Federal Government decision, commentary in the "NZZ" to changes in the Swiss pharmaceutical reimbursement & pricing scheme
by Andreas WildiPDF: 582 KB
Publications |